Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.
Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M, Harris NL, Junt T, Odermatt B, Clavien PA, Pircher H, Akira S, Hengartner H, Zinkernagel RM.
Lang KS, et al. Among authors: akira s.
J Clin Invest. 2006 Sep;116(9):2456-63. doi: 10.1172/JCI28349.
J Clin Invest. 2006.
PMID: 16955143
Free PMC article.